| Literature DB >> 31587179 |
S Rosetti1, M L Tanda1, G Veronesi2, E Masiello1, P Premoli1, D Gallo1, C Cusini1, S Donati3, J Sabatino1, S Ippolito1, E Piantanida1, L Bartalena4.
Abstract
Entities:
Keywords: Adverse events; Graves’ disease; Graves’ orbitopathy; Oral prednisone; Radioiodine; Steroid prophylaxis
Mesh:
Substances:
Year: 2019 PMID: 31587179 DOI: 10.1007/s40618-019-01126-2
Source DB: PubMed Journal: J Endocrinol Invest ISSN: 0391-4097 Impact factor: 4.256